Clinical trial
Chinese Observation Study of the Clinical Management of Bipolar Disorder
NCT01770704 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Chinese Observation Study of the Clinical Management of Bipolar Disorder
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2013
- Completion date
- July 31, 2014
- Enrollment
- 520 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.